Parkinson's Neuroprotection 2025: Three Strategies Under Review
Stem cell therapy, System Xc- pathway modulation, and Ayurvedic add-on regimens are each being evaluated as neuroprotective strategies in Parkinson's disease.
Read article
Highlights
Cardiology
PCSK9 Inhibitors Move Upstream: Evolocumab Tested in Diabetes Without Known Atherosclerosis
Endocrinology
Lorlatinib and New-Onset Diabetes Practical Monitoring for Oncologists
Hepatology
Do Condition-Specific Growth Charts Improve Care in Alagille Syndrome?
Psychiatry
Addiction Recovery: A Canadian Perspective on a Global Crisis
News
Psychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Dermatology|Perilla Oil Nanoemulsion Improves Psoriasis Scores in Mouse ModelEndocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsEndocrinology|Lorlatinib and the Enigma of Autoantibody-Negative DiabetesImmunology|Improving PID Diagnosis with Machine Learning Phenotype ProfilingHaematology|Hemophilia Normalization's Price Tag and Policy ImplicationsHepatology|ATM Germline Mutations and Liver Adenomas in Adolescents: A Clinical ReminderEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksCardiology|PCSK9 Inhibitors Move Upstream: Evolocumab Tested in Diabetes Without Known AtherosclerosisEndocrinology|Opportunistic Osteoporosis Screening from CT Scans A Validated Approach?Rheumatology|JAK Inhibitors in RA: 2025 EULAR Safety Update Redraws Risk GuidancePsychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Dermatology|Perilla Oil Nanoemulsion Improves Psoriasis Scores in Mouse ModelEndocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsEndocrinology|Lorlatinib and the Enigma of Autoantibody-Negative DiabetesImmunology|Improving PID Diagnosis with Machine Learning Phenotype ProfilingHaematology|Hemophilia Normalization's Price Tag and Policy ImplicationsHepatology|ATM Germline Mutations and Liver Adenomas in Adolescents: A Clinical ReminderEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksCardiology|PCSK9 Inhibitors Move Upstream: Evolocumab Tested in Diabetes Without Known AtherosclerosisEndocrinology|Opportunistic Osteoporosis Screening from CT Scans A Validated Approach?Rheumatology|JAK Inhibitors in RA: 2025 EULAR Safety Update Redraws Risk Guidance